These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36727626)
1. Proline-rich 11 (PRR11) promotes the progression of cutaneous squamous cell carcinoma by activating the EGFR signaling pathway. Wang S; Zhang X; Lei H; Song L; Huang Y; Kang T; Zhang M; Wang N; Yang P; Feng S; Wang J; Bai R; Wang N; Wang W; Zheng Y Mol Carcinog; 2023 May; 62(5):613-627. PubMed ID: 36727626 [TBL] [Abstract][Full Text] [Related]
2. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma. Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056 [TBL] [Abstract][Full Text] [Related]
3. Yes-Associated Protein Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma via Activation of RAS. Jia J; Li C; Luo S; Liu-Smith F; Yang J; Wang X; Wang N; Lai B; Lei T; Wang Q; Xiao S; Shao Y; Zheng Y J Invest Dermatol; 2016 Jun; 136(6):1267-1277. PubMed ID: 26902922 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K/Akt signaling pathway by downregulating EGFR. Mei XL; Zhong S Chin Med J (Engl); 2019 Feb; 132(4):454-465. PubMed ID: 30707166 [TBL] [Abstract][Full Text] [Related]
5. PRR11 Promotes Proliferation and Migration of Colorectal Cancer through Activating the EGFR/ERK/AKT Pathway via Increasing CTHRC1. Ma H; Yang W; Wang X; Dai G Ann Clin Lab Sci; 2022 Jan; 52(1):86-94. PubMed ID: 35181621 [TBL] [Abstract][Full Text] [Related]
6. Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma. Fan Z; Qin J; Wang D; Geng S J Cell Mol Med; 2019 May; 23(5):3097-3107. PubMed ID: 30825266 [TBL] [Abstract][Full Text] [Related]
7. circ_0001821 Contributes to the Development of Cutaneous Squamous Cell Carcinoma by Regulating MicroRNA-148a-3p/EGFR Axis and Activating Phosphatidylinositol 3-Kinase/Akt Pathway. Zhang Z; Deng X Mol Cell Biol; 2022 Mar; 42(3):e0008921. PubMed ID: 35191745 [TBL] [Abstract][Full Text] [Related]
8. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway. Lu D; Sun L; Li Z; Mu Z Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153 [TBL] [Abstract][Full Text] [Related]
9. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling. Wu N; Hui H; Cui L; Yang F Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927 [TBL] [Abstract][Full Text] [Related]
10. LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways. Huang Y; Wang Y; Wang Y; Wang N; Duan Q; Wang S; Liu M; Bilal MA; Zheng Y J Invest Dermatol; 2022 Feb; 142(2):303-313.e9. PubMed ID: 34358528 [TBL] [Abstract][Full Text] [Related]
12. Specific knockdown of HOXB7 inhibits cutaneous squamous cell carcinoma cell migration and invasion while inducing apoptosis via the Wnt/β-catenin signaling pathway. Gao D; Chen HQ Am J Physiol Cell Physiol; 2018 Nov; 315(5):C675-C686. PubMed ID: 30067384 [TBL] [Abstract][Full Text] [Related]
13. Chronic sun exposure-related fusion oncogenes EGFR-PPARGC1A in cutaneous squamous cell carcinoma. Egashira S; Jinnin M; Ajino M; Shimozono N; Okamoto S; Tasaki Y; Hirano A; Ide M; Kajihara I; Aoi J; Harada M; Igata T; Masuguchi S; Fukushima S; Ihn H Sci Rep; 2017 Oct; 7(1):12654. PubMed ID: 28978917 [TBL] [Abstract][Full Text] [Related]
14. RBM3 Inhibits the Cell Cycle of Cutaneous Squamous Cell Carcinoma through the PI3K/AKT Signaling Pathway. Huang Y; Sun W; Zhu D; Liu L; Feng J; Yi Q Curr Mol Pharmacol; 2024; 17():e18761429323760. PubMed ID: 39041256 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of ARMC8 promotes tumorigenesis through activating Wnt/β-catenin pathway and EMT in cutaneous squamous cell carcinomas. Li X; Zhang C; Yuan Y; Wang Y; Lu S; Zhou Z; Zhen P; Zhou M J Dermatol Sci; 2021 Jun; 102(3):184-192. PubMed ID: 34016486 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Huang Y; Ni R; Wang J; Liu Y Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440 [TBL] [Abstract][Full Text] [Related]
17. UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes. Li L; Li F; Xia Y; Yang X; Lv Q; Fang F; Wang Q; Bu W; Wang Y; Zhang K; Wu Y; Shen J; Jiang M EBioMedicine; 2020 Jul; 57():102835. PubMed ID: 32574963 [TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma. Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma. Li F; Liao J; Duan X; He Y; Liao Y J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2. Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]